Starcoin Group Limited (399) Requests Review of Listing Committee Decision on Rule 13.24

Bulletin Express

02/10

Starcoin Group Limited (formerly known as Innovative Pharmaceutical Biotech Limited), Stock Code 399, announced that the Stock Exchange of Hong Kong has determined the company did not maintain a sufficient level of operations as required under Rule 13.24 of the Listing Rules. Previous announcements dated 17 November 2025, 24 November 2025, and 2 February 2026 disclosed the decision by the Stock Exchange and the subsequent review application filed with the Listing Committee.

According to the latest disclosure, after the Listing Committee’s verdict (the “LC Decision”), a written request was submitted on 10 February 2026 to refer the matter to the Listing Review Committee. The outcome of this review remains uncertain.

Relevant stakeholders are advised to stay alert to further developments and exercise caution when dealing in the company’s securities. The board also stated it will make additional announcements if necessary under the Listing Rules.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1166255992"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1166255992\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1166255992?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-10 23:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1166255992","market":"us","top_or_hot":-1,"title":"Starcoin Group Limited (399) Requests Review of Listing Committee Decision on Rule 13.24","media":"Bulletin Express","content":"<p>Starcoin Group Limited (formerly known as Innovative Pharmaceutical Biotech Limited), Stock Code 399, announced that the Stock Exchange of Hong Kong has determined the company did not maintain a sufficient level of operations as required under Rule 13.24 of the Listing Rules. Previous announcements dated 17 November 2025, 24 November 2025, and 2 February 2026 disclosed the decision by the Stock Exchange and the subsequent review application filed with the Listing Committee.</p>\n<p>According to the latest disclosure, after the Listing Committee’s verdict (the “LC Decision”), a written request was submitted on 10 February 2026 to refer the matter to the Listing Review Committee. The outcome of this review remains uncertain.</p>\n<p>Relevant stakeholders are advised to stay alert to further developments and exercise caution when dealing in the company’s securities. The board also stated it will make additional announcements if necessary under the Listing Rules.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Starcoin Group Limited (399) Requests Review of Listing Committee Decision on Rule 13.24</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStarcoin Group Limited (399) Requests Review of Listing Committee Decision on Rule 13.24\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-02-10 23:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Starcoin Group Limited (formerly known as Innovative Pharmaceutical Biotech Limited), Stock Code 399, announced that the Stock Exchange of Hong Kong has determined the company did not maintain a sufficient level of operations as required under Rule 13.24 of the Listing Rules. Previous announcements dated 17 November 2025, 24 November 2025, and 2 February 2026 disclosed the decision by the Stock Exchange and the subsequent review application filed with the Listing Committee.</p>\n<p>According to the latest disclosure, after the Listing Committee’s verdict (the “LC Decision”), a written request was submitted on 10 February 2026 to refer the matter to the Listing Review Committee. The outcome of this review remains uncertain.</p>\n<p>Relevant stakeholders are advised to stay alert to further developments and exercise caution when dealing in the company’s securities. The board also stated it will make additional announcements if necessary under the Listing Rules.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"00399","symbol_name":"星太链集团","start_time":0,"source_url":"","article_id":"1166255992","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1166255992","pubTimestamp":1770738163,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Starcoin Group Limited (formerly known as Innovative Pharmaceutical Biotech Limited), Stock Code 399, announced that the Stock Exchange of Hong Kong has determined the company did not maintain a...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"00399":"星太链集团"},"translate_title":"星币集团有限公司(399)要求覆核上市委员会根据第13.24条作出的决定","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00399":1},"content_text":"Starcoin Group Limited (formerly known as Innovative Pharmaceutical Biotech Limited), Stock Code 399, announced that the Stock Exchange of Hong Kong has determined the company did not maintain a sufficient level of operations as required under Rule 13.24 of the Listing Rules. Previous announcements dated 17 November 2025, 24 November 2025, and 2 February 2026 disclosed the decision by the Stock Exchange and the subsequent review application filed with the Listing Committee.\nAccording to the latest disclosure, after the Listing Committee’s verdict (the “LC Decision”), a written request was submitted on 10 February 2026 to refer the matter to the Listing Review Committee. The outcome of this review remains uncertain.\nRelevant stakeholders are advised to stay alert to further developments and exercise caution when dealing in the company’s securities. The board also stated it will make additional announcements if necessary under the Listing Rules.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}